Product image of Zemplar (Paricalcitol) supplied by GNH India

Zemplar

Active Ingredient:
Paricalcitol
Origin:
EU

Zemplar (Paricalcitol)

Zemplar (Paricalcitol) is a vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This oral medication helps regulate calcium and phosphate levels. Suitable for patients requiring vitamin D receptor activation therapy. Short-term use under medical supervision is typical for this EU-manufactured treatment.

Manufacturer / TM Owner

Abbvie S.R.O. (Slovakia)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults with chronic kidney disease undergoing dialysis. It works by reducing elevated parathyroid hormone levels, which helps maintain healthy bone metabolism. Patients with kidney-related calcium imbalances may benefit from this vitamin D analog. It is not intended for general vitamin D deficiency or unrelated conditions.

Side Effects

  • Common effects of Paricalcitol include mild gastrointestinal discomfort such as nausea or vomiting. Some patients may experience dizziness or headache shortly after taking the medication. These effects are usually temporary and tend to diminish as the body adjusts. Regular monitoring is advised to assess individual tolerance.

Precautions & Warnings

  • Store Paricalcitol at room temperature away from moisture and direct light. Keep this medication out of reach of children and pets. Avoid crushing or splitting capsules unless directed by a healthcare professional. Report any persistent side effects or unusual symptoms to a medical provider promptly.

Avoid Interactions

  • Paricalcitol may interact with other vitamin D supplements, calcium-based medications, or phosphate binders. Caution is advised when combining with CYP3A4 inhibitors, as they can alter drug metabolism. Alcohol and grapefruit products may also affect how Paricalcitol works. Always inform your doctor about all medications and supplements being taken.

Frequently Asked Questions

Zemplar (Paricalcitol) is used to treat secondary hyperparathyroidism in adults with chronic kidney disease, particularly those on dialysis.

Zemplar is taken orally as directed by a healthcare provider, usually with or without food. Follow the prescribed dosing schedule carefully.

Some patients may experience mild side effects like nausea, headache, or dizziness. Most effects are temporary and should be reported if persistent.

Long-term use requires regular monitoring by a healthcare professional to assess effectiveness and safety. Do not use without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Paricalcitol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT